- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8702
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,702 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ANUP | ₹3,381.95 | -6.4% | 147.6% | ₹67.6b | ₹3,850.00 | PE56.5x | E21.5% | 0.2% | Capital Goods | ||
DOMS | ₹2,564.25 | -16.0% | 98.9% | ₹155.6b | ₹3,058.86 | PE83.8x | E23.2% | 0.1% | Commercial Services | ||
505283 | ₹1,576.45 | -3.7% | 163.0% | ₹102.2b | ₹1,833.00 | PE53.9x | E26.3% | 0.4% | Capital Goods | ||
AVL | ₹514.80 | 1.8% | n/a | ₹66.2b | ₹560.75 | PE69.5x | E26.7% | 0.2% | Retail | ||
A137400 | ₩39,500.00 | -2.9% | -20.0% | ₩918.3b | ₩82,350.00 | PE9x | E37.3% | 0% | Capital Goods | ||
ACI | ₹664.05 | 0.9% | 3.1% | ₹82.0b | ₹826.00 | PE37.3x | E41.3% | 0.5% | Materials | ||
CONCORDBIO | ₹2,151.05 | 4.5% | 42.8% | ₹225.0b | ₹2,041.25 | PE68.6x | E26.9% | 0.4% | Pharmaceuticals & Biotech | ||
A441270 | ₩5,150.00 | 6.2% | -39.4% | ₩190.4b | n/a | PS0.5x | E131.1% | n/a | Tech | ||
A178320 | ₩26,600.00 | -7.6% | 58.1% | ₩1.5t | ₩39,333.33 | PE16.1x | E39.9% | 0% | Tech | ||
A257720 | ₩31,750.00 | 2.9% | 319.4% | ₩1.9t | ₩56,750.00 | PE19.6x | E41.7% | n/a | Retail | ||
SFPTECH | RM 0.71 | 2.9% | -24.1% | RM 1.7b | RM 0.96 | PE44.4x | E28.3% | 0.6% | Capital Goods | ||
A253590 | ₩9,110.00 | -5.9% | 26.5% | ₩387.2b | n/a | PE31.2x | E61.7% | 0.3% | Semiconductors | ||
SKS | AU$1.78 | -8.5% | 547.3% | AU$199.5m | AU$2.15 | PE30.1x | E24.8% | 0.6% | Capital Goods | ||
A204270 | ₩18,870.00 | -8.4% | 53.5% | ₩1.1t | ₩24,500.00 | PS3.2x | E104.4% | n/a | Tech | ||
A067310 | ₩9,680.00 | -2.4% | -61.1% | ₩578.5b | ₩18,826.09 | PS0.5x | E110.9% | 0.4% | Semiconductors | ||
AXSM | US$87.01 | -7.0% | 9.6% | US$4.2b | US$130.47 | PS12.5x | E72.5% | n/a | Pharmaceuticals & Biotech | ||
RMDA | ج.م3.41 | -2.8% | 111.0% | ج.م5.1b | ج.م5.02 | PE19.3x | E30.7% | 2.0% | Pharmaceuticals & Biotech | ||
ALNY | US$243.25 | -1.4% | 27.2% | US$31.4b | US$299.11 | PS15x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
PHM | €79.90 | 4.4% | 86.4% | €1.4b | €83.20 | PE2253x | E56.2% | 0.8% | Pharmaceuticals & Biotech | ||
ARES | US$181.06 | 1.5% | 53.0% | US$56.5b | US$185.31 | PE84.5x | E38.4% | 2.1% | Diversified Financials | ||
ALKT | US$39.63 | 1.4% | 61.6% | US$4.0b | US$44.60 | PS12.6x | E102.7% | n/a | Software | ||
BBT | AU$0.29 | -4.9% | 48.7% | AU$164.2m | AU$0.37 | PS2.8x | E91.4% | n/a | Consumer Services | ||
FWRY | ج.م8.24 | -4.8% | 51.7% | ج.م28.1b | ج.م12.45 | PE22.7x | E27.4% | n/a | Diversified Financials | ||
TGTX | US$32.16 | -4.2% | 89.3% | US$4.6b | US$40.75 | PS17.4x | E57.0% | n/a | Pharmaceuticals & Biotech |